Neiswanger Institute for Bioethics & Health Policy Subcriber to AJOB Testimonial | Advertise with Us
News Updated: Wed Mar 17 | 1:25 PM UTC
VOL. 10 NO. 3 | March 2010
The American Journal of Bioethics | Volume 10 Number 3
Current TOC | Past Issues | The Editors

Editorial

Government Intervention and The Nation's Diet: The Slippery Slope of Inaction
by Kelly D. Brownell

Target Articles

Community Members as Recruiters of Human Subjects: Ethical Considerations
by Christian Simon, Maghboeba Mosavel

Open Peer Commentary

Trans Fat Bans and Human Freedom
by David B. Resnik

Open Peer Commentary

The Case of Samuel Golubchuk and the Right to Live
by Alan B. Jotkowitz, Shimon Glick, Ari Z. Zivotofsky

Open Peer Commentary
Book Reviews

Review of Robert M. Veatch, Patient, Heal Thyself: How the New Medicine Puts the Patient in Charge
by Ruth Levy Guyer

Correspondence

Response to Open Peer Commentaries on “Community Members as Recruiters of Human Subjects: Ethical Considerations"
by Christian Simon, Maghboeba Mosavel

Response to Open Peer Commentaries on “Trans Fat Bans and Human Freedom”
by David B. Resnik

The Secret of Caring for Mr. Golubchuk
by Alan B. Jotkowitz, Shimon Glick, Ari Z. Zivotofsky

BIOETHICS JOBS
Currently (12) positions listed

Job Posting - FREE


INSIDE BIOETHICS.NET

Report Paints Grim Picture of Drug Trial Safety
Criticism of FDA's weak oversight are on target, but Congress shares blame.

Giving Up on Gene Therapy Is Wrong Reaction
Death of Jolee Mohr should lead to new patient protections

Women Should Be Wary of Genetic Risk Ads
TV commercials exploit fear of breast cancer in the guise of education.

Students' Meningitis Shots Should Be Required
Americans hate to be told what to do, but we hate losing our kids more.

Privacy is True Price of Healthy Worker Discounts
Even fit folks should resist the temptation of lower deductibles.

BIOETHICS NEWS XML

Myriad breast cancer patent very broad, study finds
(Reuters) Myriad Genetics' disputed patent on the BRCA1 breast cancer gene is "surprisingly broad" and could interfere with future research, three experts said on Tuesday.

Dr. Murray Feingold: Drugs made just for you
(Daily News Transcript) Patients with the same diagnoses are usually treated with similar medications. However, not all patients respond the same way to the same treatment. Some get better, others do not.

Euthanasia's Slippery Slope
(The Mark) For millennia, euthanasia has been considered morally and legally unjustifiable. People who oppose euthanasia still believe it's inherently wrong – it can't be morally justified and even compassionate motives don't make it ethically acceptable. But what are the attitudes of pro-euthanasia advocates regarding whether its use needs to be justified, were it to be legalized? And, if justifications are required, what are they?

The ethics of paying kidney donors
(WHYY News) A new study seems to knock down some of the ethical objections to paying people to donate an organ. The study authors are with the University of Pennsylvania and the Philadelphia VA Medical Center.

With Medicaid Cuts, Doctors and Patients Drop Out
(New York Times) As she began a punishing regimen of chemotherapy and radiation, Mrs. Vliet found a measure of comfort in her monthly appointments with her primary care physician, Dr. Saed J. Sahouri, who had been monitoring her health for nearly two years. She was devastated, therefore, when Dr. Sahouri informed her a few months later that he could no longer see her because, like a growing number of doctors, he had stopped taking patients with Medicaid.

Featured Article
infocus Government Intervention and The Nation's Diet: The Slippery Slope of Inaction
by Kelly D. Brownell



WEEKLY UPDATE
Enter your email to receive FREE Weekly News Updates

Subscribe Unsubscribe




THIS WEEK


BIOETHICS BOOKSTORE
Bookstore From Embryology to Evo-Devo: A History of Developmental Evolution
by Manfred D. Laubichler, Jane Maienschein
The MIT Press (2007)